RAPT Therapeutics (NASDAQ:RAPT) Bolsa, Quote.MetaTitle.unusual-options

RAPT Therapeutics

RAPT Therapeutics Inc

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma

Astria Therapeutics

ArriVent BioPharma

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

Bicara Therapeutics

CareDx

CytomX Therapeutics

Erasca

Geron

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

Gyre Therapeutics

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

Lexeo Therapeutics

MeiraGTx Hldgs

MoonLake Immunotherapeutics - Class A Ordinary Shares

MoonLake

MapLight Therapeutics, Inc. - Common Stock

MapLight Therapeutics

Anbio Biotechnology - Class A Ordinary Shares

Anbio Biotechnology

Prime Medicine

Replimune Group

Rigel Pharmaceuticals, Inc. - Common Stock

Rigel Pharmaceuticals

ARS Pharmaceuticals

Savara

Tyra Biosciences

Valneva

Vir Biotechnology

RAPT Therapeutics (RAPT) Previsión

Noticias

Beneficios

Opciones

Calificaciones de analistas

Operaciones de insiders

Interés en corto

Informe de acciones

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Comments

RAPT Therapeutics Opciones Inusuales

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL